Success Metrics

Clinical Success Rate
87.5%

Based on 14 completed trials

Completion Rate
88%(14/16)
Active Trials
1(4%)
Results Posted
21%(3 trials)
Terminated
2(8%)

Phase Distribution

Ph phase_1
2
8%
Ph phase_2
6
23%
Ph phase_3
6
23%
Ph not_applicable
12
46%

Phase Distribution

2

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
2(7.7%)
Phase 2Efficacy & side effects
6(23.1%)
Phase 3Large-scale testing
6(23.1%)
N/ANon-phased studies
12(46.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

73.7%

14 of 19 finished

Non-Completion Rate

26.3%

5 ended early

Currently Active

1

trials recruiting

Total Trials

26

all time

Status Distribution
Active(2)
Completed(14)
Terminated(5)
Other(5)

Detailed Status

Completed14
Withdrawn3
unknown3
Terminated2
Suspended2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (7.7%)
Phase 26 (23.1%)
Phase 36 (23.1%)
N/A12 (46.2%)

Trials by Status

completed1454%
terminated28%
withdrawn312%
recruiting14%
unknown312%
suspended28%
enrolling_by_invitation14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT07356440Not Applicable

Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly

Enrolling By Invitation
NCT05351905Not Applicable

Improving Pain Disability With the Use of Oral Cannabinoids

Completed
NCT06686914Phase 1

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

Recruiting
NCT02919631Phase 2

Triheptanoin in Mc Ardle

Completed
NCT04969900Not Applicable

Effects of Aromatherapy on Patient Satisfaction With Surgical Abortion at Less Than 10 Weeks Gestation

Completed
NCT01748448Phase 3

Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

Completed
NCT06217146Not Applicable

A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.

Terminated
NCT04549662Not Applicable

The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) Trial

Completed
NCT03642860Phase 2

The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses

Completed
NCT05892276Not Applicable

Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms

Withdrawn
NCT04197102Phase 2

Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

Suspended
NCT04603781Phase 2

CBD Oil for Reducing Emotional Impact of COVID-19

Suspended
NCT03167307Phase 3

The Omega-3 Fatty Acid Paediatric Depression Trial

Completed
NCT03690791Phase 3

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

Unknown
NCT01669200Not Applicable

Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment

Completed
NCT05306704Phase 3

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Completed
NCT03328676Phase 2

The Effect of Cannabis on Dementia Related Agitation and Aggression

Completed
NCT04726475Phase 1

Impact of CBD-Rich Oil on Aversive Memory Reconsolidation

Unknown
NCT05102331Not Applicable

Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures

Withdrawn
NCT04569760Phase 3

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Withdrawn

Drug Details

Intervention Type
OTHER
Total Trials
26